About 4 300 reports

  • Active Pharmaceutical Ingredient Market: Revenue in USD billion, Biotech, Global, 2015-2023
  • Revenue (%), by Geography, 2017

The global active pharmaceutical ingredients market is expected to register a CAGR of approximately 6.2% during the forecast period (2018 - 2023). Active pharmaceutical ingredients are any substance or combination of substances used in a finished pharmaceutical product with pharmacological activity. The expenditure on research & development,...

  • Pharmaceutical
  • Company
  • Forecast
  • Market Size
  • Supply
  • Geistlich Pharma AG - Key Employees
  • Geistlich Pharma AG - Key Employee Biographies

Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company...

  • Biomaterial
  • Pharmaceutical
  • Company
  • Market Size
  • Geistlich Group
  • Ego Pharmaceuticals Pty Ltd, History
  • Ego Pharmaceuticals Pty Ltd, Subsidiaries

Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Body Care
  • Pharmaceutical
  • Australia
  • Company
  • Trade

PHARMA LEADER SERIES: ## TOP BIOSIMILAR DRUG MANUFACTURERS 2017-2027 ##.

  • Biopharmaceutical
  • Biosimilar
  • Pharmaceutical
  • China
  • Company
  • Galenica's Net Sales Share by Region (2016)
  • Galenica's Net Sales Share by Business Segments (2016)

Vifor Pharma is an international specialty pharma company that researches, develops, produces and markets its own pharmaceutical products.

  • Pharmaceutical
  • Company
  • Forecast
  • Market Segment
  • Market Size
  • 4.3 ANTARES PHARMA INC
  • 4.2.1 Company Overview

Italy Needle Free Injections Market Outlook to 2023 Summary GlobalData’s new report, "Italy Needle Free Injections Market Outlook to 2023", provides key market data on the Italy Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Needle...

  • Pharmaceutical
  • Italy
  • Company
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc.

PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018 Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 Intermountain Healthcare Inc' s, deal volume decreased from one pharmaceuticals & healthcare d

  • Pharmaceutical
  • United States
  • Company
  • GlobalData's company
  • Intermountain Gas Company
  • Kracie Holdings, Ltd. - Business Description
  • Name

Kracie Holdings, Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute company...

  • Pharmaceutical
  • Company
  • Forecast
  • Market Size
  • Supply
  • ROCHE SWOT ANALYSIS, 2017
  • provides a SWOT analysis of Roche.

OBI Pharma (2016).

  • Pharmaceutical
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • EARLY-STAGE DRUGS IN CLINICAL DEVELOPMENT FOR ME, 2017
  • Clinical Trial Summary for Phase II Trial, RUBY

The acquisition was completed in March 2015 and created one of the world' s TOP ## PHARMACEUTICAL COMPANIES BASED AROUND A NEW " GROWTH PHARMA" BUSINESS MODEL (ALLERGAN, PRESS RELEASE, MARCH ##, 2015).

  • Pharmaceutical
  • Targeted Therapy
  • Therapy
  • Type 2 Diabetes
  • Company
  • COMPANY PORTFOLIO GAP ANALYSIS IN COPD, 2015-2025
  • CHF-5993 (BECLOMETHASONE DIPROPIONATE + FORMOTEROL FUMARATE + GLYCOPYRROLATE)

SOURCE: GLOBALDATA, PHARMA ETRACK [ACCESSED DECEMBER ##, 2016] FOR IMMEDIATE RELIEF OF SYMPTOMS, THE USUAL ADULT DOSE IS ONE PUFF (##MCG).

  • Pharmaceutical
  • Company
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • KEY COMPANIES IN THE OSTEOPOROSIS MARKET IN THE 7MM, 2018
  • ANNUAL COST OF ORAL BISPHOSPHATES

Springer-Verlag, ##(##), pp. ##-##. doi: ##. ##/ s##-##- ##-##.

  • Pharmaceutical
  • World
  • Company
  • Amgen Inc.
  • Eli Lilly & Co.
  • Advanced/Stage IV/Metastatic Pipeline Projects for Previously Approved Drug Molecules
  • a. Business Overview

RCC Market Patent Trend by Top Inventors Merck ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer ## ## ## ## ## ## ## ## ## ## ## ## ## ## Roche ## ## ## ## ## ## ## ## ## ## ## ## ## ## NIH ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Genentech ## ## ## ## ## ## ## ## ##

  • Pharmaceutical
  • Company
  • Argos Therapeutics, Inc.
  • AstraZeneca PLC
  • AVEO Oncology
  • 4.3 ANTARES PHARMA INC
  • 4.2.1 Company Overview

France Needle Free Injections Market Outlook to 2023 Summary GlobalData’s new report, "France Needle Free Injections Market Outlook to 2023", provides key market data on the France Needle Free Injections market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for...

  • Pharmaceutical
  • France
  • Company
  • Antares Pharma, Inc.
  • Bioject Medical Technologies Inc.
  • LEFITOLIMOD'S CLINICAL DEVELOPMENT IN CRC
  • KEYTRUDA'S CLINICAL DEVELOPMENT IN CRC

TABLE ##: PRODUCT PROFILE - TS-## TAHIO PHARMACEUTICALS' TS-## WAS APPROVED IN 2003 FOR THE TREATMENT OF MCRC.

  • Pharmaceutical
  • Company
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • OTHER DRUGS IN PHASE II OF CLINICAL DEVELOPMENT FOR HIV, 2016
  • VIIV'S DOLUTEGRAVIR/LAMIVUDINE - PHASE III CLINICAL TRIALS

THE SAFETY AND EFFICACY OF THE NOVEL PI-BASED COMBINATION IS CURRENTLY BEING EVALUATED IN TWO PHASE III CLINICAL TRIALS IN TREATMENT-NAÏVE AND TREATMENT-EXPERIENCED HIV-##-INFECTED ADULTS (JANSSEN PHARMACEUTICALS, NCT##; JANSSEN PHARMACEUTICALS, NCT##).

  • Pharmaceutical
  • East Asia
  • Company
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.
  • MERCK'S PSORIASIS PORTFOLIO SWOT ANALYSIS, 2015
  • PRODUCT PROFILE - REMICADE

INTERNATIONAL JOURNAL OF PHARMA WORLD RESEARCH; ##(##): ##-##.

  • Pharmaceutical
  • World
  • Company
  • Amgen Inc.
  • Merck & Co., Inc.
  • TETRAPHASE PHARMACEUTICALS INC. N/A
  • COMPANY PORTFOLIO GAP ANALYSIS FOR HAIS AGAINST GRAM-NEGATIVE BACTERIA, 2016-2026

PharmaPoint: Healthcare-Associated Gram-Negative Infections - Global Drug Forecast and Market Analysis to 2026 Summary Bacterial infections represent a frequent occurrence in humans. Fortunately, a majority of these infections are successfully eliminated by the native and adaptive immune system. The majority of remaining...

  • Anti-Infective
  • Hospital
  • Pharmaceutical
  • Therapy
  • Company
  • OTHER PRODUCTS IN CLINICAL DEVELOPMENT FOR HCV INFECTION, 2016
  • CLINICAL DEVELOPMENT OUTSIDE 9MM, 2016

Trends; ##(##):##-##.

  • Pharmaceutical
  • Company
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • 5.3.1. COMPANY OVERVIEW
  • DRUG DISCOVERY PLATFORMS

PRECLINICAL PIPELINE ## ## AO-## AO-## Pharmaceuticals / Biomea Fusion A##A Pharmaceuticals P Solid tumors P Leukemia ## ## ASC-ST.

  • Pharmaceutical
  • North America
  • United States
  • World
  • Company
  • 5.3.3. COMPANY PROFILE: CONIFER POINT PHARMACEUTICALS
  • PRESENTS A BRIEF PROFILE OF CONIFER POINT PHARMACEUTICALS, HIGHLIGHTING ITS OFFERINGS FOR CADD PORTFOLIO.

INTRODUCTION The early stages of research related to drug discovery, including the identification of a relevant biological target and a viable lead compound, play a crucial role in the overall success of a drug candidate in preclinical and clinical studies. It is also worth noting that the process of drug discovery is extremely...

  • Pharmaceutical
  • Company
  • Market Size
  • BioNTech AG.
  • Evotec AG
  • KITE PHARMA: COMPANY PROFILE
  • PROVIDES A BRIEF PROFILE OF KITE PHARMA.

INTRODUCTION Amidst the current initiatives to develop more targeted anti-cancer therapies, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a potent and viable therapeutic intervention to eradicate tumor cells, with minimal side effects. It is based on the principle of harnessing the innate potential of...

  • Pharmaceutical
  • China
  • Company
  • Juno Therapeutics Inc.
  • Novartis AG

China is one of the emerging markets for pharmacovigilance, due to the growing demand for modern pharmaceuticals.

  • Pharmaceutical
  • Company
  • BioClinica, Inc.
  • PAREXEL International Corporation
  • Wipro Limited
  • Pfizer
  • 18 Moebius Medical

INTRODUCTION Chronic pain refers to the psychophysiological response to an underlying clinical condition, which is observed to persist for a duration greater than six months and is generally unresponsive to multiple treatment regimens. It is estimated that more than 1.5 billion individuals across the world suffer from this...

  • Pharmaceutical
  • North America
  • United States
  • Company
  • Eli Lilly & Co.
  • DISHMAN PHARMA: BUSINESS UNITS
  • EXTENT OF OUTSOURCING IN PHARMACEUTICAL OPERATIONS

INTRODUCTION Amongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business model to a network of suppliers. As such, contract manufacturing has evolved as one of the integral components of the pharmaceutical...

  • Pharmaceutical
  • North America
  • United States
  • Company
  • Biologics, Inc.
  • 10.5 VITHERA PHARMACEUTICALS
  • Business Overview

The global human microbiome market is expected to account for nearly USD 273.40 million, registering a CAGR of about 22.6% during 2018-2025 (the forecast period). Moreover, the market is expected to reach USD 757.26 million by 2025. Increasing Incidence of Lifestyle Diseases The rising incidence of lifestyle diseases at the global...

  • Pharmaceutical
  • United States
  • Company
  • Enterome Bioscience SA
  • Synlogic, Inc.
  • 6.3 COMPANY PROFILES
  • 6.2 TRENDS IN CORPORATE STRATEGY

PUBLIC HEALTH GENOMICS; ##(##): ##-##.

  • Pharmaceutical
  • Company
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • bioMerieux S.A.
  • AVELUMAB'S DEVELOPMENT IN RCC
  • AVEO ONCOLOGY'S RCC PORTFOLIO ASSESSMENT, 2016

AVEO AND ITS MARKETING PARTNER EUSA PHARMA FILED AN MAA TO THE EMA FOR TIVOZANIB FOR THE FIRSTLINE TREATMENT OF RCC IN Q## 2016 (EUSA PHARMA, PRESS RELEASE, MARCH ##, 2016).

  • Pharmaceutical
  • Company
  • Eisai Co., Ltd.
  • Exelixis, Inc.
  • Pfizer Inc.
  • NOVARTIS' NSCLC PORTFOLIO ASSESSMENT, 2016
  • BMS SWOT ANALYSIS IN NSCLC, 2016

THE EFFICACY OF ZYKADIA WAS EVALUATED IN THE ASCEND-## TRIAL, A PHASE I, SINGLE-ARM, OPEN-LABEL STUDY (STUDY ##) (NOVARTIS PHARMACEUTICALS, NCT##).

  • Pharmaceutical
  • Company
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • KEY COMPANIES IN THE G/GEJAC MARKET IN THE 8MM, 2014-2024
  • SUMMARY OF RESULTS FROM A PHASE II TRIAL OF ABRAXANE

TS-## IS MARKETED BY NORDIC PHARMA UNDER THE BRAND NAME TEYSUNO.

  • Pharmaceutical
  • Company
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.